Welcome, Guest. Please login or register.
September 19, 2020, 11:37:43 am

Login with username, password and session length

  • Total Posts: 55016
  • Total Topics: 4800
  • Online Today: 59
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 45
Total: 45


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: No Link Between Hep C Treatment With DAAs and Liver Cancer Risk  (Read 1916 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 760
    • Hep Mag
No Link Between Hep C Treatment With DAAs and Liver Cancer Risk
« on: January 22, 2018, 10:19:42 am »
Direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) does not apparently raise the risk of hepatocellular carcinoma (HCC, the most common form of liver cancer) compared with interferon treatment, Healio reports. Previous reports of such a link between DAAs and liver cancer were likely biased by differences in baseline risk factors for liver cancer between those treated with interferon versus DAAs.

Regardless of treatment type, treating hep C is indeed associated with a lower risk of liver cancer.



© 2020 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.